BPC 157: Miracle Healing Peptide or Hidden Danger? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida May 19, 2025: Investigations raise questions about product safety at a Texas compounding company Partnership for Safe Medicines In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for